Radiology societies weigh in on FDA push to regulate generative AI

Radiology societies have responded to the FDA's push to regulate generative AI. The article does not detail their specific recommendations or any regulatory timeline.

• Report flags legal risks of AI-generated drug evidence2026-10-21
• AI Tool Tumor Site Risk Wins FDA Clearance2026-10-16
• Study: AI could cut medical device recalls2026-09-24